Cefcanel daloxate
Cefcanel daloxate (KY-109 (free base) ) is an orally active cephalosporin prodrug against Gram-positive bacteria and Haemophilus influenzae. Cefcanel daloxate is promising for research of uremia[1].
Product Specifications
CAS Number
97275-40-6
Product Name Alternative
KY-109 (free base)
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cefcanel-daloxate.html
Smiles
O=C1OC(COC(C2=C(CSC3=NN=C(C)S3)CS[C@@]([C@@H]4NC([C@@H](C5=CC=CC=C5)OC([C@@H](N)C)=O)=O)([H])N2C4=O)=O)=C(C)O1
Molecular Formula
C27H27N5O9S3
Molecular Weight
661.73
References & Citations
[1]Edwall B, et al. Pharmacokinetics of oral cefcanel daloxate hydrochloride in healthy volunteers and patients with various degrees of impaired renal function. J Antimicrob Chemother. 1994 Feb;33 (2) :281-8.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
